Medtronic (NYSE:MDT) announced today that it enrolled the first patient in a study for its Braive growth modulation system. Fridley, Minn.-based Medtronic also completed the first surgical procedure in the BRAIVE investigational device exemption (IDE) study evaluating the safety and effectiveness of the Braive growth modulation system for treating progressive adolescent idiopathic scoliosis. The first […]
Implants
Medtronic’s Pipeline Flex problems expand
The FDA today issued a notice confirming a Class I recall of the Pipeline Flex embolization device from Medtronic (NYSE:MDT). Several models of the Pipeline Flex embolization device and Pipeline Flex embolization device with Shield Technology were affected, with 8,825 devices recalled in the U.S., having been distributed between April 18, 2019, and Aug. 13, […]
Stryker launches new Citrelock tendon fixation device system
Stryker (NYSE:SYK) announced today that its trauma & extremities division launched its Citrelock tendon fixation device system. According to a news release, the Citrelock system offers surgeons a differentiated design through a tendon thread featuring a resorbable technology — Citregen — with unique chemical and mechanical properties for orthopedic surgical applications. Citrelock features a controlled […]
Ivantis to pay $60M in patent litigation settlement with Glaukos
Glaukos (NYSE:GKOS) announced today that it entered into a settlement with Ivantis to terminate a three-year-old patent infringement lawsuit. San Clemente, California-based Glaukos’ patent infringement lawsuit, initiated on April 14, 2018, in the U.S. District Court for the Central District of California, Southern Division, concerned Ivantis’ Hydrus Microstent for reducing eye pressure in glaucoma patients. Get the full […]
Lyra Therapeutics appoints new CFO
Lyra Therapeutics (NSDQ:LYRA) announced today that it appointed Jason Cavalier as its new chief financial officer, effective today. Cavalier succeeds the company’s current CFO, Don Elsey, who is retiring while he remains expected to serve in an advisory role to assist with the transition. Get the full story at our sister site, Drug Delivery Business News.
Lyra touts non-human trial of XTreo drug-eluting implant
Lyra Therapeutics (NSDQ:LYRA) is touting preclinical data for its XTreo drug-eluting implant for dosing in local sinus tissues. Watertown, Massachusetts-based Lyra’s preclinical results were published — “Drug Release and Pharmacokinetic Evaluation of Novel Implantable Mometasone Furoate Matrices in Rabbit Maxillary Sinuses” — were published online in the peer-review journal, American Journal of Rhinology & Allergy. Get the […]
Corin Group picks head of Medtronic’s spine business as its CEO
Corin Group announced today that it appointed former Medtronic executive Jacob Paul as its new CEO. Cirencester, U.K.–based Corin Group said in a news release that Paul “brings unparalleled strategic and operational experience” to the company and is “well placed” to lead it through the next phase of its mission to improve patient activity and […]
Glaukos submits supplemental PMA application for iStent Infinite
Glaukos (NYSE:GKOS) announced today that it submitted a supplemental premarket approval application to the FDA for its iStent Infinite system. San Clemente, California–based Glaukos designed the iStent Infinite trabecular micro-bypass system for use in a standalone procedure to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma uncontrolled by prior surgery or medical therapy. Get […]
Bioventus triggers $50M option to acquire CartiHeal
Bioventus (NSDQ:BVS) announced today that it chose to make a $50 million escrow payment to acquire CartiHeal and its Agili-C implant. Durham, N.C.-based Bioventus elected to make its escrow payment pursuant to its option and equity purchase agreement with CartiHeal to signal its intent to move forward with an acquisition of the company. According to […]
Smith+Nephew touts analysis of Oxinium in total hip arthroplasty
Smith+Nephew (NYSE:SNN) today touted its Oxinium technology as the best performing bearing with the lowest revision risk in total hip arthroplasty. London Based S+N shared results substantiated by four national and regional joint registries over the last 20 years, covering more than 2 million procedures from which to draw, according to a news release. The […]
Zimmer Biomet, Canary Medical win FDA de novo nod for smart knee implant
Zimmer Biomet (NYSE:ZBH) and Canary Medical announced today that the FDA granted de novo classification for Persona IQ. The de novo grant and marketing authorization comes for the tibial extension for Persona IQ, which the companies tout as the first and only smart knee implant cleared by the FDA for total knee replacement surgery. (Canary […]
